HomeChoice Automated Peritoneal Dialysis system, 230V 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Baxter Healthcare 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-10-21
  • 사례 출판 날짜
    2013-10-21
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: baxter homechoice automated peritoneal dialysis system, 230v medical device manufacturer, baxter healthcare, has issued a field safety notice concerning homechoice automated peritoneal dialysis system, 230v (product code: 5c4474; software version: v10.4). baxter is sending a communication to describe homechoice 10.4 software initial drin logic in patients with unrelated co-morbid condition of ascites. ascites is the abnormal accumulation of fluid in the peritoneal cavity. peritoneal dialysis patients with ascites may have large volumes of fluid in their peritoneal cavity. when these patients drain significant amounts of ascetic fluid (e.G. more than 5 liters), studies suggest that medical intervention may be required to mitigate against developing hypotension and potential hemodynamic compromise. homechoice software is designed to empty the peritoneal cavity during initial drain. previous versions of homechoice software permitted the operator to stop the active initial drain and bypass it. the current version of the homechoice software version 10.4 removed the option to bypass an active initial drain in order to mitigate against unintended increased intraperitoneal volume. patients diagnosed with the co-morid condition of ascites who drain to empty may be at an increase risk of hypotension and compromise of their hemodynamic status. therefore, baxter advises that clinicians using the homechoice to treat patients diagnosed with end stage renal disease coincident with ascites should: be aware that homechoice will attempt to drain the patient to empty at the beginning of therapy (initial drain) review homechoice ifu for additional details on homechoice 10.4 initial drain logic. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 21 october 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Baxter HomeChoice Automated Peritoneal Dialysis system, 230V
  • Manufacturer

Manufacturer